Related content

REIC/Dkk-3-encoding adenoviral vector as a potentially effective therapeutic agent for bladder cancer

By Hirata Takeshi   Watanabe Masami   Kaku Haruki   Kobayashi Yasuyuki   Yamada Hiroshi   Sakaguchi Masakiyo   Takei Kohji   Huh Nam-Ho   Nasu Yasutomo   Kumon Hiromi  

International Journal of Oncology, Vol. 41, Iss. 2, 2012-08 ,pp. : 559-564

Spandidos Publications

Access to resources Recommend Favorite

Adenovirusmediated REIC/Dkk3 gene therapy: Development of an autologous cancer vaccination therapy (Review)

By      

Oncology Letters, Vol. 7, Iss. 3, 2014-01 ,pp. : 595-601

Spandidos Publications

Access to resources Recommend Favorite

Partial sensitization of human bladder cancer cells to a gene-therapeutic adenovirus carrying REIC/Dkk-3 by downregulation of BRPK/PINK1

By Jin Yu   Murata Hitoshi   Sakaguchi Masakiyo   Kataoka Ken   Watanabe Masami   Nasu Yasutomo   Kumon Hiromi   Huh Nam-Ho  

Oncology Reports, Vol. 27, Iss. 3, 2012-03 ,pp. : 695-699

Spandidos Publications

Access to resources Recommend Favorite

Preclinical biodistribution and safety study of reduced expression in immortalized cells/Dickkopf-3-encoding adenoviral vector for prostate cancer gene therapy

By                    

Oncology Reports, Vol. 28, Iss. 5, 2012-01 ,pp. : 1645-1652

Spandidos Publications

Access to resources Recommend Favorite

The cysteine-rich core domain of REIC/Dkk-3 is critical for its effect on monocyte differentiation and tumor regression

By              

Oncology Reports, Vol. 33, Iss. 6, 2015-01 ,pp. : 2908-2914

Spandidos Publications

Access to resources Recommend Favorite